Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.59 | N/A |
| PEG Ratio (TTM) | 0.36 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | -4.61 | N/A |
| P/FCF Ratio (TTM) | -1,005.74 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.74% | N/A |
| ROE (TTM) | 3.23% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 59.76% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 8.18% | N/A | N/A |
| Cash Flow | 71.45% | N/A | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.01 | N/A |
| Quick Ratio (TTM) | 0.01 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 8.93 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |